Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) has provided an announcement.
Shanghai Pharmaceuticals Holding Co., Ltd., a joint stock company incorporated in China, announced a proposed acquisition of a 10% equity interest in Finance Company from SIIC Dongtan for RMB143,335,577.71. This transaction will increase the company’s direct holding in Finance Company to 40%. The acquisition is considered a connected transaction under Hong Kong’s Listing Rules, requiring reporting and annual review but exempt from circular and independent shareholders’ approval. The agreement is pending execution, and the company will announce once definitive agreements are entered.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$15.70 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Average Trading Volume: 6,746,231
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$70.39B
See more data about 2607 stock on TipRanks’ Stock Analysis page.